Daily Journal Staff Writer
The $200 million initial public offering completed Wednesday by Pacific Biosciences of California Inc. hit right in the middle of its capital-raising target.
The company, which makes DNA-sequencing technology for biotech researchers, was advised by Larry W. Sonsini and Donna M. Petkanics at Wilson Sonsini Goodrich & Rosati in the sale of 12.5 million shares for $16 each, raising $182.5 million af...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In